PHIO PHARMACEUTICALS CORP. Lease, Cost
PHIO PHARMACEUTICALS CORP. (PHIO) reported Lease, Cost of $102.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2020-03-26
- PHIO PHARMACEUTICALS CORP. lease, cost for fiscal 2019 was $102.00K.
- PHIO PHARMACEUTICALS CORP. lease, cost for fiscal 2018 was $0.00.
| Period end | Lease, Cost 12 month |
|---|---|
| 2019-12-31 | $102.00K 10-K · filed 2020-03-26 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |